What Patients Need to Know About Oral Immunotherapy for Peanut Allergy as FDA approaches approval

Two large trials, DREAM and MENSA have found IL-5 therapy with mepolizumab to lower risk of exacerbation in patients with asthma with an eosinophilic phenotype.

Mold allergy is difficult to diagnose due to lack of standardized test material.

The current standard for diagnosis of Eosinophilic Esophagitis (EoE) is endoscopy with esophageal biopsy to determine the eosinophil count

Skin prick testing and serum IgE measurement are limited in their ability to predict positive or negative responses to oral peanut challenge.

Bronchial Thermoplasty (BT) has been shown to result in significant improvements in a number of asthma control measures in three randomized clinical trials in patients with moderate-to-severe, persistent asthma.

Recent studies have suggested that early regular exposure to allergenic foods may reduce the risk of food allergy.